HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.0
  1. Home
  2. /Compound

Etoperidone

HCID 40589
New noteNew reactionRequest quotes
Print preview
Basic informationOverviewNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
52942-31-1
Standard SMILES
CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CC
InChIKey
IZBNNCFOBMGTQX-UHFFFAOYSA-N
Molecular formula
C19H28ClN5O
Average molar mass
377.9 g/mol
Monoisotopic mass
377.1982382

Overview

Etoperidone is a member of piperazines.

Names & identifiers

Preferred name
Etoperidone
IUPAC
2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-4,5-diethyl-1,2,4-triazol-3-one
English name
ETOPERIDONE
Molecular formula
C19H28ClN5O
Molecular weight
377.91

Names & synonyms

ETOPERIDONE52942-31-1EtoperidonaEtoperidonumKAI6MVO39ZDTXSID0023034(1,3-(4-m-chlorophenyl-1-piperazinyl)propyl)-3,4-diethyl-delta(2)-1,2,4-triazolin-5-one1-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}-3,4-diethyl-4,5-dihydro-1H-1,2,4-triazol-5-one1-(3-(4-(3-chlorophenyl)piperazin-1-yl)propyl)-3,4-diethyl-4,5-dihydro-1H-1,2,4-triazol-5-oneRefChem:139281DTXCID803034N06AB09
Show more names
2-[3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl]-4,5-diethyl-2H-1,2,4-triazol-3(4H)-one3H-1,2,4-Triazol-3-one, 2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-4,5-diethyl-2,4-dihydro-
2-(3-(4-(m-chlorophenyl)-1-piperazinyl)propyl)-4,5-diethyl-2,4-dihydro-3H-1,2,4-triazolo-3-one.HClEtoperidone [INN]2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-4,5-diethyl-1,2,4-triazol-3-oneEtoperidona [Spanish]UNII-KAI6MVO39ZEtoperidonum [INN-Latin]Etoperidona [INN-Spanish]IZBNNCFOBMGTQX-UHFFFAOYSA-N

Database identifiers

CAS
52942-31-1
PubChem CID
40589
DTXSID
DTXSID0023034
ChEMBL
CHEMBL1743259
ChEBI
CHEBI:135589
UNII
KAI6MVO39Z
Nikkaji
J9.735G

Properties

Computed structural properties

XLogP
3
Topological polar surface area
42.4 Ų
Hydrogen bond donors
0
Hydrogen bond acceptors
4
Rotatable bonds
7
Heavy atoms
26
Formal charge
0
Complexity
506

Experimental & physicochemical properties

DrugsPharmaceuticals -> Listed in ZINC15
Boiling Point499ºC at 760mmHg
Melting Point197-198 ºC

Physicochemical properties

Boiling point
0.5 · bp0.5 230°
form
Oil
FDA UNII
6 MVO39Z · KAI6MVO39Z
ATC code
6 AB09 · N06AB09

Chemistry & industry

Pharmacology

ATC Code · 2 items

N - Nervous system

QN - Nervous system

Protein BindingEtoperidone presents an extensive plasma protein binding.
Pharmacodynamics · 1 item

Etoperidone has a biphasic effect on the central transmission of serotonin. It presents the capacity to inhibit serotonin receptor but also to inhibit the reuptake of serotonin, norepinephrine and dopamine. As part of its actions, etoperidone also inhibits the α-adrenergic receptors which directly corresponds to the sedative and cardiovascular effects. The presence of both effects caused that the effective dose of etoperidone was poorly tolerated thus, efforts have been made to separate the serotonergic and adrenergic functions in order to generate etoperidone-derivatives like nefazodone.

Mechanism of Action · 1 item

The activity of etoperidone is made mainly by its major metabolite 1-(3'-chlorophenyl)piperazine (mCPP). mCPP binds with different affinity to most of the serotonergic receptors and adrenergic receptors. This metabolite is an agonist of 5-HT2c and an antagonist of 5-HT2a. Part of etoperidone structure contibutes to the activity in the α-adrenergic receptors.

Biological Half-LifeAfter oral administration of etoperidone the terminal half-life was 21.7 hours.
Metabolism/Metabolites · 2 items

Etoperidone is highly metabolized and it forms 21 different metabolites that can be found in plasma, urine and faeces. The metabolism of etoperidone is thought to be related to 5 different reaction pathways that are alkyl oxidation, piperazinyl oxidation, N-dealkylation, phenyl hydroxylation and conjugation.

Etoperidone has known human metabolites that include 2-[3-[4-(3-chloro-4-hydroxyphenyl)piperazin-1-yl]propyl]-4,5-diethyl-1,2,4-triazol-3-one, 2-[3-[4-(3-Chlorophenyl)piperazin-1-yl]propyl]-4-ethyl-5-(1-hydroxyethyl)-1,2,4-triazol-3-one, 4,5-diethyl-2-propyl-1,2,4-triazol-3-one, and 1-(3-Chlorophenyl)piperazine.

Absorption, Distribution and Excretion

Related reactions

0 records
New reaction record

No reaction records under the current filter.

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes
More actions
New noteNew reactionRequest quotes
· 4 items

The absorption and bioavailability is highly variable between individuals and can be as low as 12%. The lower bioavailability is explained due to its high metabolism. The mean time to peak plasma concentration is ranged from 1.4-4.8 hours.

The elimination of an oral dose of etoperidone presents a division of 78.8% found in urine and 9.6% found in faeces. On the elimination route, less than 0.01% of the etoperidone dose is represented by the unchanged drug while the rest is formed by 21 different metabolites.

The high protein binding presented in etoperidone modulates its volume of distribution to a range of 0.23 to 0.69 L/kg.

The apparent clearance of etoperidone was 1.01 ml/min.

Applications

UsesAntidepressant.

Upstream & downstream products

Upstream raw materials

Hydrochloric acidSodiumSodium hydride1-Bromo-3-chloropropane

Additional notes

DefinitionChEBI: Etoperidone is a member of piperazines.